medindia
  1. Medindia
  2. Health Tips and Quotations

Strimvelis: Gene Therapy for Bubble Baby Disease

It has been one year since GlaxoSmithKline''s gene therapy Strimvelis for treating ADA- deficient Severe combined immunodeficiency (ADA-SCID) has been approved for sale in Europe. However, the cost of the treatment which amounts to 594,000 Euros has limited its sale. The National Institute for Health and Care Excellence (NICE) has in an unprecedented manner approved GSK''s pricey gene therapy, Strimvelis, as an option to treat the rare immune deficiency condition.

NICE approves GlaxoSmithKline''s Pricey Gene Therapy-Strimvelis - A one-time treatment that could cure a rare immune-deficient condition:SCID - Could be a second choice of treatment when matched stem cell donors are unavailable

GSK's Gene Therapy, Strimvelis, for 'bubble Baby Disease' Gets NICE's Approval

The National Institute for Health and Care Excellence has approved GSK's gene therapy, Strimvelis, as an option to treat a rare immune deficiency condition. Read More

Related Links

Slim Down Naturally With Ash Gourd Juice
Do You Get Drowsy At Work After Having Lunch?
Eating Right at Night: Choosing the Best Foods for Evening Health
Menopause and Heart Health: Protecting Your Cardiovascular Wellness
Savor Strawberries Everyday to Keep Dementia at Bay
High-Protein Breakfast: Your Path to Body Fat Loss
Why Does Foot Swelling Occur While Flying?
Mood Foods: What to Eat and What to Avoid for Better Mental Health
Men's Health Signals You Should Not Ignore
Top 5 Everyday Habits That Affect Your Vision
Harness the Healing Power of Avocado Seed Tea
Nutritional Guide to Staying Healthy During the Monsoon Season

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024